KRTAP22-1: A Potential Drug Target Or Biomarker (G337979)

Target Name: KRTAP22-1

NCBI ID: G337979

KRTAP22-1

Other Name(s): KAP22.1 | Keratin associated protein 22-1 | Keratin-associated protein 22-1 | KR221_HUMAN | keratin associated protein 22-1

KRTAP22-1: A Potential Drug Target Or Biomarker

KRTAP22-1 (KAP22.1) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the Kallikrein family of proteins, which are involved in the regulation of cell signaling pathways.

KRTAP22-1 has been identified as a potential drug target or biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. Its unique structure and expression pattern have also made it a promising candidate for diagnostic applications.

The Kallikrein family of proteins is characterized by the presence of a catalytic domain and a non-catalytic region that is involved in protein-protein interactions. KRTAP22-1 is no exception to this general structure, as it contains a catalytic domain that is responsible for the catalytic activity of the protein, as well as a non-catalytic region that is involved in protein-protein interactions and other functions.

One of the unique features of KRTAP22-1 is its expression pattern. KRTAP22-1 is highly expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is also expressed in various types of cancer, which makes it an attractive target for cancer therapies. Additionally, KRTAP22-1 is also expressed in neurodegenerative disorders, which makes it a potential target for therapies aimed at treating these conditions.

KRTAP22-1 has also been shown to play a role in the regulation of cell signaling pathways. It has been shown to interact with various proteins, including the protein known as FAK (focal adhesion kinase). This interaction between KRTAP22-1 and FAK has been shown to play a role in the regulation of cell signaling pathways, including the regulation of cell migration and the regulation of the production of cell surface proteins.

In addition to its potential role in cell signaling pathways, KRTAP22-1 has also been shown to have potential as a diagnostic biomarker. Its unique expression pattern and the presence of various types of cancer in its expression have made it an attractive candidate for diagnostic applications. Additionally, KRTAP22-1 has been shown to have a high stability and a low mobility, which makes it a good candidate for imaging applications.

In conclusion, KRTAP22-1 is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. Its unique structure and expression pattern make it an attractive candidate for diagnostic applications, as well as for therapeutic applications. Further research is needed to fully understand the role of KRTAP22-1 in cell signaling pathways and its potential as a diagnostic biomarker.

Protein Name: Keratin Associated Protein 22-1

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP22-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP22-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets